VOR — Vor Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00
- $65.25m
- -$20.69m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -10.8 | -43.3 | -68.9 | -92.1 | -118 |
Depreciation | |||||
Non-Cash Items | 0.748 | 2.12 | 7.33 | 17.1 | 13.4 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.145 | 4.32 | -9.01 | -12.7 | 0.65 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -9.86 | -36.3 | -69.1 | -85.1 | -100 |
Capital Expenditures | -0.748 | -4.16 | -3.89 | -8.46 | -1.07 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | -87.8 | -85.6 | 72.1 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.748 | -4.16 | -91.7 | -94.1 | 71 |
Financing Cash Flow Items | — | — | -2.21 | 0 | -0.717 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 17.7 | 82.5 | 233 | 117 | 2.94 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 7.1 | 42.1 | 72.1 | -62.1 | -26.3 |